Literature DB >> 4587517

Cross-over study of ten tetracycline preparations.

J Tuomisto, P Männistö.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4587517     DOI: 10.1007/bf00561804

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Clinical pharmacology of the tetracycline antibiotics.

Authors:  C M KUNIN; M FINLAND
Journal:  Clin Pharmacol Ther       Date:  1961 Jan-Feb       Impact factor: 6.875

2.  Absorption and excretion of five tetracycline analogues in normal young men.

Authors:  N H Steigbigel; C W Reed; M Finland
Journal:  Am J Med Sci       Date:  1968-05       Impact factor: 2.378

3.  Serum levels of tetracycline after different administration forms.

Authors:  A E Altmann; H Beeuwkes; P J Brombacher; H J Buytendijk; A H Gijzen; F P Maesen
Journal:  Clin Chim Acta       Date:  1968-05       Impact factor: 3.786

4.  Interference of iron with the absorption of tetracyclines in man.

Authors:  P J Neuvonen; G Gothoni; R Hackman; K Björksten
Journal:  Br Med J       Date:  1970-11-28

5.  Assessment of the biologic availability of tetracycline products in man.

Authors:  W H Barr; L M Gerbracht; K Letcher; M Plaut; N Strahl
Journal:  Clin Pharmacol Ther       Date:  1972 Jan-Feb       Impact factor: 6.875

  5 in total
  5 in total

1.  Bioavailability of commercial tetracycline products.

Authors:  D B Barnett; R N Smith; N D Greenwood; C Hetherington
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

2.  Inhibition of iron absorption by tetracycline.

Authors:  P J Neuvonen; P J Pentikäinen; G Gothoni
Journal:  Br J Clin Pharmacol       Date:  1975-02       Impact factor: 4.335

3.  The bioavailability of sixteen tetracycline products.

Authors:  M C Meyer; R E Dann; P L Whyatt; G W Slywka
Journal:  J Pharmacokinet Biopharm       Date:  1974-08

4.  Bioavailability and dissolution of different formulations of oxytetracycline preparations.

Authors:  A Hart; H E Barber; T N Calvey
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

5.  Comparative bioavailability of tetracycline and lymecycline.

Authors:  G Sjölin-Forsberg; J Hermansson
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.